Catalent Current Ratio 2012-2019 | CTLT

Current and historical current ratio for Catalent (CTLT) from 2012 to 2019. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations. Catalent current ratio for the three months ending June 30, 2019 was 2.08.
Catalent Current Ratio Historical Data
Date Current Assets Current Liabilities Current Ratio
2019-06-30 $1.40B $0.67B 2.08
2019-03-31 $1.14B $0.53B 2.18
2018-12-31 $1.07B $0.51B 2.08
2018-09-30 $1.08B $0.53B 2.05
2018-06-30 $1.24B $0.58B 2.15
2018-03-31 $1.21B $0.56B 2.18
2017-12-31 $1.08B $0.48B 2.22
2017-09-30 $1.33B $0.46B 2.91
2017-06-30 $1.06B $0.47B 2.26
2017-03-31 $0.93B $0.39B 2.38
2016-12-31 $0.88B $0.34B 2.64
2016-09-30 $0.77B $0.45B 1.71
2016-06-30 $0.79B $0.39B 2.02
2016-03-31 $0.73B $0.37B 1.96
2015-12-31 $0.68B $0.34B 2.00
2015-09-30 $0.69B $0.35B 1.96
2015-06-30 $0.74B $0.40B 1.85
2015-03-31 $0.65B $0.37B 1.79
2014-12-31 $0.64B $0.35B 1.84
2014-09-30 $0.62B $0.38B 1.64
2014-06-30 $0.69B $0.45B 1.52
2014-03-31 $0.63B $0.41B 1.52
2013-12-31 $0.68B $0.41B 1.65
2013-09-30 $0.00B 0.00
2013-06-30 $0.68B $0.41B 1.66
2013-03-31 $0.00B 0.00
2012-06-30 $0.71B $0.44B 1.60
2011-06-30 $0.00B 0.00
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $7.424B $2.518B
Catalent, Inc. provides advanced delivery technologies and development solutions for drugs, biologics and consumer health products. It operates through Oral Technologies, Medication Delivery Solutions, and Development & Clinical Services. The Oral Technologies segment address the full diversity of the pharmaceutical industry including small molecules, large molecule biologics and consumer health products. The Medication Delivery Solutions segment offers formulation, development, and manufacturing services for delivery of drugs and biologics administered through injection, inhalation, and ophthalmic routes. The Development and Clinical Services segment provides manufacturing, packaging, storage, and inventory management services for drugs and biologics in clinical trials. Catalent, Inc. is headquartered in Somerset, New Jersey.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $58.463B 36.01
Astellas Pharma (ALPMY) Japan $27.878B 13.28
Takeda Pharmaceutical (TAK) Japan $27.185B 8.49
UCB SA (UCBJF) Belgium $14.267B 0.00
Eisai (ESALY) Japan $14.254B 24.51
Merck (MKGAF) Germany $14.152B 19.31
Grifols, S.A (GRFS) Spain $13.648B 17.41
Ono Pharmaceutical (OPHLF) Japan $9.383B 20.06
Neurocrine Biosciences (NBIX) United States $9.287B 0.00
Ionis Pharmaceuticals (IONS) United States $9.102B 19.63
IPSEN SA ADR (IPSEY) France $8.529B 0.00
Sage Therapeutics (SAGE) United States $8.489B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $7.461B 9.82
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) Italy $7.257B 19.83
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $5.781B 0.00
STADA ARZNEIMI (STDAF) Germany $5.547B 0.00
Orion OYJ (ORINY) Finland $5.275B 27.16
Hypermarcas (HYPMY) Brazil $5.052B 18.16
United Therapeutics (UTHR) United States $3.765B 0.00
Nektar Therapeutics (NKTR) United States $3.628B 0.00
FibroGen (FGEN) United States $3.599B 90.02
Evotec AG (EVTCY) Germany $3.399B 46.53
Taro Pharmaceutical Industries (TARO) Israel $3.166B 11.35
Tilray (TLRY) Canada $2.978B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $2.801B 64.22
PTC Therapeutics (PTCT) United States $2.554B 0.00
Portola Pharmaceuticals (PTLA) United States $2.102B 0.00
Xencor (XNCR) United States $2.068B 45.10
Zogenix (ZGNX) United States $1.887B 0.00
Heron Therapeutics (HRTX) United States $1.707B 0.00
USANA Health Sciences (USNA) United States $1.588B 15.92
Pacira Pharmaceuticals (PCRX) United States $1.580B 57.50
CLINIGEN GP (CLIGF) United Kingdom $1.577B 0.00
Corcept Therapeutics (CORT) United States $1.534B 21.08
Ironwood Pharmaceuticals (IRWD) United States $1.490B 0.00
Enanta Pharmaceuticals (ENTA) United States $1.357B 22.39
Radius Health (RDUS) United States $1.343B 0.00
Theravance Biopharma (TBPH) Cayman Islands $1.283B 0.00
Spectrum Pharmaceuticals (SPPI) United States $1.065B 0.00
Aerie Pharmaceuticals (AERI) United States $1.047B 0.00
ArQule (ARQL) United States $0.952B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $0.948B 4.23
Endo (ENDP) Ireland $0.928B 1.63
TherapeuticsMD (TXMD) United States $0.921B 0.00
Karyopharm Therapeutics (KPTI) United States $0.723B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.676B 0.00
Concordia (CXRXF) Canada $0.674B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.586B 0.00
Akebia Therapeutics (AKBA) United States $0.566B 0.00
Translate Bio (TBIO) United States $0.561B 0.00
Lannett Co Inc (LCI) United States $0.556B 5.86
Organogenesis Holdings (ORGO) United States $0.552B 0.00
Flexion Therapeutics (FLXN) United States $0.552B 0.00
Aptorum Group (APM) China $0.492B 0.00
ImmunoGen (IMGN) United States $0.481B 0.00
Dermira (DERM) United States $0.472B 0.00
Indivior (INVVY) United States $0.468B 1.69
Siga Technologies (SIGA) United States $0.467B 1.09
Innate Pharma SA (IPHYF) France $0.455B 0.00
Dova Pharmaceuticals (DOVA) United States $0.450B 0.00
ChemoCentryx (CCXI) United States $0.440B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.428B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.426B 19.39
Collegium Pharmaceutical (COLL) United States $0.406B 0.00
Harpoon Therapeutics (HARP) United States $0.379B 0.00
DURECT (DRRX) United States $0.365B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.361B 0.00
OptiNose (OPTN) United States $0.347B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.321B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.307B 0.00
CV Sciences (CVSI) United States $0.302B 0.00
Ardelyx (ARDX) United States $0.294B 0.00
Xeris Pharmaceuticals (XERS) United States $0.290B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.278B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.277B 0.00
Rafael Holdings (RFL) United States $0.272B 0.00
Recro Pharma (REPH) United States $0.268B 0.00
Concert Pharmaceuticals (CNCE) United States $0.264B 0.00
KalVista Pharmaceuticals (KALV) United States $0.261B 0.00
Molecular Templates (MTEM) United States $0.236B 0.00
Calithera Biosciences (CALA) United States $0.215B 0.00
Foamix Pharmaceuticals (FOMX) Israel $0.215B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.207B 0.00
Ocular Therapeutix (OCUL) United States $0.203B 0.00
GlycoMimetics (GLYC) United States $0.203B 0.00
Nature's Sunshine Products (NATR) United States $0.189B 31.55
CannTrust Holdings (CTST) Canada $0.183B 0.00
Generex Biotechnology (GNBT) United States $0.174B 0.00
Redhill Biopharma (RDHL) Israel $0.169B 0.00
Taiwan Liposome (TLC) Taiwan $0.160B 0.00
IMV INC (IMV) Canada $0.155B 0.00
MEI Pharma (MEIP) United States $0.142B 0.00
Oasmia Pharmaceutical AB (OASMY) Sweden $0.135B 0.00
Cardiome Pharma (CORV) Canada $0.126B 0.00
ElectroCore (ECOR) United States $0.120B 0.00
Jounce Therapeutics (JNCE) United States $0.112B 0.00
Majesco Entertainment (PTE) United States $0.109B 0.00
Mast Therapeutics (SVRA) United States $0.108B 0.00
ALLERGY THERAPT (AGYTF) United Kingdom $0.108B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.106B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.105B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.104B 0.00
Neos Therapeutics (NEOS) United States $0.094B 0.00
AgeX Therapeutics (AGE) United States $0.093B 0.00
Genocea Biosciences (GNCA) United States $0.092B 0.00
MediWound (MDWD) Israel $0.092B 0.00
Aquestive Therapeutics (AQST) United States $0.091B 0.00
Iterum Therapeutics (ITRM) Ireland $0.091B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.089B 0.00
RENEURON GP (RNUGF) United Kingdom $0.084B 0.00
Nivalis Therapeutics (ALPN) United States $0.077B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.075B 28.59
Aclaris Therapeutics (ACRS) United States $0.074B 0.00
Jaguar Animal Health (JAGX) United States $0.074B 0.00
Natural Alternatives (NAII) United States $0.073B 7.30
Lipocine (LPCN) United States $0.070B 0.00
Novan (NOVN) United States $0.070B 0.00
Champions Oncology (CSBR) United States $0.069B 592.00
Infinity Pharmaceuticals (INFI) United States $0.068B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.067B 0.00
Otonomy (OTIC) United States $0.066B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.062B 0.00
SCYNEXIS (SCYX) United States $0.061B 0.00
China SXT Pharmaceuticals (SXTC) China $0.059B 0.00
Capnia (SLNO) United States $0.058B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.053B 0.00
CTI BioPharma (CTIC) United States $0.049B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.047B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.046B 0.00
Melinta Therapeutics (MLNT) United States $0.046B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.046B 1.59
Forward Pharma (FWP) Denmark $0.045B 0.00
India Globalization Capital (IGC) United States $0.042B 0.00
Mannatechorporated (MTEX) United States $0.039B 0.00
Bio-Path Holdings (BPTH) United States $0.034B 0.00
Opexa Therapeutics (ACER) United States $0.034B 0.00
PharmAthene (ALT) United States $0.033B 0.00
Biomerica (BMRA) United States $0.031B 0.00
IsoRay (ISR) United States $0.021B 0.00
Heat Biologics (HTBX) United States $0.020B 0.00
ProPhase Labs (PRPH) United States $0.019B 0.00
Achieve Life Sciences (ACHV) United States $0.018B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.018B 0.00
Regulus Therapeutics (RGLS) United States $0.017B 0.00
HANCOCK JAFFE (HJLI) United States $0.017B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.016B 0.00
Vical (BBI) United States $0.015B 0.00
Shineco (TYHT) China $0.014B 0.00
Cyanotech (CYAN) United States $0.014B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.013B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.011B 0.00
Onconova Therapeutics (ONTX) United States $0.011B 0.00
VAXART, INC (VXRT) United States $0.010B 0.00
RXi Pharmaceuticals (PHIO) United States $0.009B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.009B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
Hemispherx BioPharma (AIM) United States $0.004B 0.00
Flex Pharma (SLRX) United States $0.004B 0.00
Midatech Pharma (MTP) United Kingdom $0.004B 0.00
Cytori Therapeutics Inc (PSTV) United States $0.004B 0.00
Can-Fite Biopharma (CANF) Israel $0.003B 0.00
Advanced Accelerator Applications S.A (AAAP) France $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00